Developer docs
API playgroundTry for free, no card

Search company profiles

Society of Urologic Oncology

Full company profile

uuid002n8a2

Namestring
Society of Urologic Oncology
Legal namestring
Society of Urologic Oncology
Websiteurl
suonet.org
Company typeenum
Private
Founded yearint
1984
Descriptiontext

The Society of Urologic Oncology (SUO) is a US-based non-profit professional medical society founded in 1984 and headquartered in Schaumburg, Maryland. It serves as the specialty-level coordinating body for urologic oncologists, fellows, residents, allied health professionals, and the institutions that train them, with membership tiers spanning Active, Senior, Honorary, International, Allied Health Professional Corresponding, Affiliate, and Candidate categories. Its core programs include an Annual Scientific Meeting (26th Annual Meeting held in Phoenix in December 2025; 27th Annual Meeting scheduled for San Diego in December 2026), a 2026 SUO Resident Course, ACGME-aligned fellowship accreditation and match services, the official peer-reviewed Urologic Oncology journal, the Find a Provider patient directory, clinical guidelines, a Visiting Professor Grant Program, the SUO Career Center operated with Naylor, Inc., and an awards program that includes the Whitmore Lectureship, Huggins Medal, SUO Medal, Smith Mentorship Award, Young Investigator Award, and other recognitions.

SUO operates a community-led, event-driven go-to-market. Its revenue mechanics combine recurring membership dues, one-time annual meeting registration and industry sponsorship fees, institutional fellowship accreditation/match program fees, and job posting revenue from the Career Center. Two affiliated subgroups — Young Urologic Oncologists (YUO) and Western Urologic Oncologists (WUO) — extend the society's programming to early-career and regional segments, and a co-sponsored SUO-EAU Exchange Lectures program links membership value to international exchange with the European Association of Urology. The 2025 partnership with Ferring Pharmaceuticals to fund the NMIBC Fellows Research Grant is illustrative of how SUO monetizes its accredited-fellow channel via industry-funded research instruments.

Operationally, SUO is lean, with 1-10 employees on the firmographic and outsourced service providers (WJ Weiser & Associates for suonet.org hosting; Naylor, Inc. for the Career Center platform). Leadership is vested in a Board of Directors, an Executive Committee, and named program committees, with Jeffrey M. Holzbeierlein identified as President. The society is privately held as a non-profit, with no parent company, subsidiaries, or outside equity ownership disclosed.

Short descriptiontext

SUO is a US non-profit professional medical society founded in 1984 that accredits urologic oncology fellowship programs, hosts annual and resident educational meetings, publishes the Urologic Oncology journal, and serves physician members, trainees, and allied health professionals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSchaumburg, United States
HQ citystring
Schaumburg
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
urologic oncology society, professional medical membership, urology fellowship training, oncology clinical guidelines, medical research grants
Industry2 codes
1Urologic Oncology
CodeHLAKAOABPrimaryYes
2Genitourinary Oncology
CodeHLAKAFAMPrimaryNo
NAICS code1 code
  • Professional, Scientific, and Technical Services541
SIC code1 code
  • Services-Membership Organizations8600
Product category
Professional Medical Society Services
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Membership Dues
TypeSubscription Recurring
Description

Professional society membership fees from physicians and healthcare professionals in urologic oncology

suonet.org
2Annual Meeting Registration
TypeOne Time License
Description

Conference registration fees for annual meetings such as the 26th Annual Meeting (December 2025) and 27th Annual Meeting (December 2026)

suonet.org
3Fellowship Programs
TypeProfessional Services
Description

Institutional accreditation and match program fees for urologic oncology fellowship training programs

suonet.org
4Career Center Services
TypeSubscription Recurring
Description

Job posting and employer services through the SUO Career Center platform connecting employers with urology professionals

careers.suonet.org
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Society of Urologic Oncology (SUO) is a non-profit professional medical society that serves urologic oncology physicians through membership tiers (Active, Senior, Honorary, International, Allied Health, Affiliate, Candidate), an annual scientific meeting, ACGME-approved fellowship accreditation and match program, clinical practice guidelines, a peer-reviewed Urologic Oncology journal, and recognition through awards such as the Whitmore Lectureship, Huggins Medal, and SUO Medal. It also operates a Career Center platform and administers research grants including the NMIBC Fellows Research Grant with Ferring Pharmaceuticals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Two researchers funded annually through SUO NMIBC Fellows Research Grant program
Product overview1 text field

The Society of Urologic Oncology (SUO) is a professional medical society that serves its members through an annual meeting, fellowship accreditation programs, membership services, awards, and educational resources. The organization operates the SUO Career Center for job placement, publishes the Urologic Oncology Journal, and maintains regional divisions including Young Urologic Oncologists (YUO) and Western Urologic Oncologists (WUO). Additional offerings include clinical guidelines, a visiting professor grant program, and a provider finder directory for patients.

Product and service8 records
1SUO Annual Meeting
CategoryConferences and Education
Description

Annual scientific meeting bringing together urologic oncology professionals for education, research presentations, accredited courses, abstract submissions, and industry partner exhibitions.

2SUO Fellowship Program
CategoryFellowship Training Accreditation
Description

ACGME-approved fellowship accreditation, centralized match program, curriculum standards, and institutional oversight for urologic oncology training programs.

3SUO Career Center
CategoryRecruitment Services
Description

Online job board and recruitment platform connecting healthcare employers with urologic oncology professionals, featuring job postings, resume services, and premium employer branding.

4SUO Membership
CategoryProfessional Membership
Description

Professional membership offering multiple categories (Active, Senior, Honorary, International, Allied Health Professional Corresponding, Affiliate, Candidate) with benefits including CME tracking, member directory, certificates, and newsletter access.

5Urologic Oncology Journal
CategoryAcademic Publishing
Description

Peer-reviewed scientific journal publishing original investigations and seminars in urologic oncology research.

6SUO NMIBC Fellows Research Grant
CategoryResearch Grant Funding
Description

Research grant funding two clinical research investigators annually working on bladder cancer, specifically non-muscle invasive bladder cancer (NMIBC), supported in partnership with Ferring Pharmaceuticals.

7SUO Clinical Practice Guidelines
CategoryClinical Resources
Description

Clinical practice guidelines and recommendations for urologic oncology diagnosis and treatment protocols.

8Visiting Professor Grant Program
CategoryEducational Programs
Description

Program providing funding and support for visiting professors to speak at SUO member institutions, promoting education and knowledge sharing in urologic oncology.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-03
Description

SUO and Ferring Pharmaceuticals partnered to create the SUO Non-Muscle Invasive Bladder Cancer (NMIBC) Fellows Research Grant. The grant supports clinical research investigators working on bladder cancer, specifically NMIBC. Two researchers receive funding through this grant annually. The application process ends in February 2026 with results presented in 2027.

2Young Urologic Oncologists (YUO)
Strategic tierCoreTypeOthers
Description

YUO is an affiliated subgroup of SUO focused on young and early-career urologic oncologists. The group operates its own committees, bylaws, membership, directory, exchange programs, webinar series, and awards including YUO Podium Selections and YUO Paper of the Year Award.

suonet.org
3Western Urologic Oncologists (WUO)
Strategic tierCoreTypeOthers
Description

WUO is a regional affiliated group of SUO covering western United States. The organization has its own executive committee, history, bylaws, membership, and directory. WUO Best Abstracts are recognized at SUO annual meetings.

suonet.org
Strategic tierKeyTypeStrategic or Co-development Partner
Description

SUO and EAU jointly sponsor the SUO EAU Exchange Lectures, an international exchange lectureship program allowing collaboration between American and European urologic oncology professionals.

Strategic tierCoreTypeOthers
Description

SUO publishes and maintains the peer-reviewed Urologic Oncology journal (urologiconcology.org), the official journal of the society publishing research in urologic oncology including original investigations and seminars.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

SUO partners with BackTable for the BackTable Urology Podcast, with podcast highlights featured on the SUO resources page to provide educational content to members.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Allied-health counterpart society with overlapping audience (SUO has an Allied Health Professional Corresponding membership tier); runs annual meetings, CE programs, and a journal aimed at non-physician urology clinicians.

TypeBroad incumbent
Description

Larger and broader urology society offering annual meetings, journals, guidelines, fellowships and advocacy; overlaps directly with SUO's educational, fellowship accreditation, and CME missions, but serves all urologists rather than just urologic oncologists.

TypeBroad incumbent
Description

The dominant U.S. oncology professional society running large annual meetings, journals (JCO), fellowships, and member education programs; competes for attention and industry sponsorship from the same urologic oncology audience, particularly on the systemic-therapy side of GU cancers.

TypeDirect peer
Description

Specialty oncology society with parallel revenue streams (annual meeting, membership dues, journal, fellowships) and overlapping treatment-area content for GU cancers, particularly prostate and bladder radiotherapy education.

TypeRegional player
Description

International urology society headquartered outside the U.S. with global congresses, training programs, and scholarships; complements SUO's North American base and intersects through international membership and education programming.

TypeRegional player
Description

EU-based peer society and existing SUO partner through the EAU Exchange Lectures; offers annual congresses, guidelines, and subspecialty sections (including oncologic urology) that directly overlap with SUO's content scope but serve a different geography.

7Society of Genitourinary Reconstructive Surgeons (GURS)
TypeDirect peer
Description

Niche urologic subspecialty society with a comparable operating model (membership, meeting, fellowships, peer-reviewed journal) that intersects with SUO's training-program landscape.

TypeDirect peer
Description

Major cancer research society operating annual meetings (AACR Annual Meeting), high-impact journals (Cancer Research, Clinical Cancer Research), grant programs, and awards; competes for the same research-active members and pharma grant dollars as SUO.

9Society for Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
TypeDirect peer
Description

Smaller subspecialty urology society offering membership, annual meeting, fellowships, and a peer-reviewed journal; the closest structural match in size and operational footprint within the urology subspecialty space.

TypeDirect peer
Description

Specialty surgical society with a comparable operating model: membership tiers, annual meeting, fellowship oversight, awards, and a focused oncology niche—making it one of the closest structural analogs to SUO in scale and program mix.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Society of Urologic Oncology

Professional Medical Society Servicessuonet.org

SUO is a US non-profit professional medical society founded in 1984 that accredits urologic oncology fellowship programs, hosts annual and resident educational meetings, publishes the Urologic Oncology journal, and serves physician members, trainees, and allied health professionals.

What Society of Urologic Oncology does

The Society of Urologic Oncology (SUO) is a US-based non-profit professional medical society founded in 1984 and headquartered in Schaumburg, Maryland. It serves as the specialty-level coordinating body for urologic oncologists, fellows, residents, allied health professionals, and the institutions that train them, with membership tiers spanning Active, Senior, Honorary, International, Allied Health Professional Corresponding, Affiliate, and Candidate categories. Its core programs include an Annual Scientific Meeting (26th Annual Meeting held in Phoenix in December 2025; 27th Annual Meeting scheduled for San Diego in December 2026), a 2026 SUO Resident Course, ACGME-aligned fellowship accreditation and match services, the official peer-reviewed Urologic Oncology journal, the Find a Provider patient directory, clinical guidelines, a Visiting Professor Grant Program, the SUO Career Center operated with Naylor, Inc., and an awards program that includes the Whitmore Lectureship, Huggins Medal, SUO Medal, Smith Mentorship Award, Young Investigator Award, and other recognitions.

SUO operates a community-led, event-driven go-to-market. Its revenue mechanics combine recurring membership dues, one-time annual meeting registration and industry sponsorship fees, institutional fellowship accreditation/match program fees, and job posting revenue from the Career Center. Two affiliated subgroups — Young Urologic Oncologists (YUO) and Western Urologic Oncologists (WUO) — extend the society's programming to early-career and regional segments, and a co-sponsored SUO-EAU Exchange Lectures program links membership value to international exchange with the European Association of Urology. The 2025 partnership with Ferring Pharmaceuticals to fund the NMIBC Fellows Research Grant is illustrative of how SUO monetizes its accredited-fellow channel via industry-funded research instruments.

Operationally, SUO is lean, with 1-10 employees on the firmographic and outsourced service providers (WJ Weiser & Associates for suonet.org hosting; Naylor, Inc. for the Career Center platform). Leadership is vested in a Board of Directors, an Executive Committee, and named program committees, with Jeffrey M. Holzbeierlein identified as President. The society is privately held as a non-profit, with no parent company, subsidiaries, or outside equity ownership disclosed.

Society of Urologic Oncology firmographics

Firmographics
Name
Society of Urologic Oncology
Legal name
Society of Urologic Oncology
Website
https://suonet.org
Company type
Private
Founded year
1984
Operating status
Operating
Headcount range
1–10 employees
Short description
SUO is a US non-profit professional medical society founded in 1984 that accredits urologic oncology fellowship programs, hosts annual and resident educational meetings, publishes the Urologic Oncology journal, and serves physician members, trainees, and allied health professionals.
Ownership category
akta.pro rank

Society of Urologic Oncology industry classification

Industry
Product category
Professional Medical Society Services
NAICS
Professional, Scientific, and Technical Services (541)
SIC
Services-Membership Organizations (8600)
akta.pro primary industry
Urologic Oncology (HLAKAOAB)
akta.pro secondary industry
Genitourinary Oncology (HLAKAFAM)

Keywords

  • Urologic oncology society
  • Professional medical membership
  • Urology fellowship training
  • Oncology clinical guidelines
  • Medical research grants

Where Society of Urologic Oncology is headquartered

Location

Headquarters

HQ city
Schaumburg
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Society of Urologic Oncology business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Membership Dues: Professional society membership fees from physicians and healthcare professionals in urologic oncology
  2. Annual Meeting Registration: Conference registration fees for annual meetings such as the 26th Annual Meeting (December 2025) and 27th Annual Meeting (December 2026)
  3. Fellowship Programs: Institutional accreditation and match program fees for urologic oncology fellowship training programs
  4. Career Center Services: Job posting and employer services through the SUO Career Center platform connecting employers with urology professionals

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Society of Urologic Oncology product offering

Product offering

Core offering

The Society of Urologic Oncology (SUO) is a non-profit professional medical society that serves urologic oncology physicians through membership tiers (Active, Senior, Honorary, International, Allied Health, Affiliate, Candidate), an annual scientific meeting, ACGME-approved fellowship accreditation and match program, clinical practice guidelines, a peer-reviewed Urologic Oncology journal, and recognition through awards such as the Whitmore Lectureship, Huggins Medal, and SUO Medal. It also operates a Career Center platform and administers research grants including the NMIBC Fellows Research Grant with Ferring Pharmaceuticals.

Product overview

The Society of Urologic Oncology (SUO) is a professional medical society that serves its members through an annual meeting, fellowship accreditation programs, membership services, awards, and educational resources. The organization operates the SUO Career Center for job placement, publishes the Urologic Oncology Journal, and maintains regional divisions including Young Urologic Oncologists (YUO) and Western Urologic Oncologists (WUO). Additional offerings include clinical guidelines, a visiting professor grant program, and a provider finder directory for patients.

Differentiator

Problem solved

Functional benefit

Products and services

  • SUO Annual Meeting Annual scientific meeting bringing together urologic oncology professionals for education, research presentations, accredited courses, abstract submissions, and industry partner exhibitions.
  • SUO Fellowship Program ACGME-approved fellowship accreditation, centralized match program, curriculum standards, and institutional oversight for urologic oncology training programs.
  • SUO Career Center Online job board and recruitment platform connecting healthcare employers with urologic oncology professionals, featuring job postings, resume services, and premium employer branding.
  • SUO Membership Professional membership offering multiple categories (Active, Senior, Honorary, International, Allied Health Professional Corresponding, Affiliate, Candidate) with benefits including CME tracking, member directory, certificates, and newsletter access.
  • Urologic Oncology Journal Peer-reviewed scientific journal publishing original investigations and seminars in urologic oncology research.
  • SUO NMIBC Fellows Research Grant Research grant funding two clinical research investigators annually working on bladder cancer, specifically non-muscle invasive bladder cancer (NMIBC), supported in partnership with Ferring Pharmaceuticals.
  • SUO Clinical Practice Guidelines Clinical practice guidelines and recommendations for urologic oncology diagnosis and treatment protocols.
  • Visiting Professor Grant Program Program providing funding and support for visiting professors to speak at SUO member institutions, promoting education and knowledge sharing in urologic oncology.

Quantifiable outcome

  • Two researchers funded annually through SUO NMIBC Fellows Research Grant program

Companies that use Society of Urologic Oncology

Customer profile

Segments4 records

Ideal customer profiles3 records

Society of Urologic Oncology technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Society of Urologic Oncology partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core, key and minor.

  • Ferring PharmaceuticalscoreStrategic or Co-development Partner · 3 December 2025SUO and Ferring Pharmaceuticals partnered to create the SUO Non-Muscle Invasive Bladder Cancer (NMIBC) Fellows Research Grant. The grant supports clinical research investigators working on bladder cancer, specifically NMIBC. Two researchers receive funding through this grant annually. The application process ends in February 2026 with results presented in 2027.
  • Young Urologic Oncologists (YUO)coreOthersYUO is an affiliated subgroup of SUO focused on young and early-career urologic oncologists. The group operates its own committees, bylaws, membership, directory, exchange programs, webinar series, and awards including YUO Podium Selections and YUO Paper of the Year Award.
  • Western Urologic Oncologists (WUO)coreOthersWUO is a regional affiliated group of SUO covering western United States. The organization has its own executive committee, history, bylaws, membership, and directory. WUO Best Abstracts are recognized at SUO annual meetings.
  • European Association of Urology (EAU)keyStrategic or Co-development PartnerSUO and EAU jointly sponsor the SUO EAU Exchange Lectures, an international exchange lectureship program allowing collaboration between American and European urologic oncology professionals.
  • Urologic Oncology JournalcoreOthersSUO publishes and maintains the peer-reviewed Urologic Oncology journal (urologiconcology.org), the official journal of the society publishing research in urologic oncology including original investigations and seminars.
  • BackTableminorStrategic or Co-development PartnerSUO partners with BackTable for the BackTable Urology Podcast, with podcast highlights featured on the SUO resources page to provide educational content to members.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Society of Urologic Oncology competitors and assessment

Company assessment

Direct peers

  • Society of Urologic Nurses and Associates (SUNA): Allied-health counterpart society with overlapping audience (SUO has an Allied Health Professional Corresponding membership tier); runs annual meetings, CE programs, and a journal aimed at non-physician urology clinicians.
  • American Society for Radiation Oncology (ASTRO): Specialty oncology society with parallel revenue streams (annual meeting, membership dues, journal, fellowships) and overlapping treatment-area content for GU cancers, particularly prostate and bladder radiotherapy education.
  • Society of Genitourinary Reconstructive Surgeons (GURS): Niche urologic subspecialty society with a comparable operating model (membership, meeting, fellowships, peer-reviewed journal) that intersects with SUO's training-program landscape.
  • American Association for Cancer Research (AACR): Major cancer research society operating annual meetings (AACR Annual Meeting), high-impact journals (Cancer Research, Clinical Cancer Research), grant programs, and awards; competes for the same research-active members and pharma grant dollars as SUO.
  • Society for Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU): Smaller subspecialty urology society offering membership, annual meeting, fellowships, and a peer-reviewed journal; the closest structural match in size and operational footprint within the urology subspecialty space.
  • Society of Surgical Oncology (SSO): Specialty surgical society with a comparable operating model: membership tiers, annual meeting, fellowship oversight, awards, and a focused oncology niche—making it one of the closest structural analogs to SUO in scale and program mix.

Broad incumbents

  • American Urological Association (AUA): Larger and broader urology society offering annual meetings, journals, guidelines, fellowships and advocacy; overlaps directly with SUO's educational, fellowship accreditation, and CME missions, but serves all urologists rather than just urologic oncologists.
  • American Society of Clinical Oncology (ASCO): The dominant U.S. oncology professional society running large annual meetings, journals (JCO), fellowships, and member education programs; competes for attention and industry sponsorship from the same urologic oncology audience, particularly on the systemic-therapy side of GU cancers.

Regional players

  • Société Internationale d'Urologie (SIU): International urology society headquartered outside the U.S. with global congresses, training programs, and scholarships; complements SUO's North American base and intersects through international membership and education programming.
  • European Association of Urology (EAU): EU-based peer society and existing SUO partner through the EAU Exchange Lectures; offers annual congresses, guidelines, and subspecialty sections (including oncologic urology) that directly overlap with SUO's content scope but serve a different geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Society of Urologic Oncology social profiles

Digital presence

Society of Urologic Oncology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Society of Urologic Oncology leadership team

Management profile

Number of profiles

Profiles1 record

Society of Urologic Oncology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Society of Urologic Oncology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Society of Urologic Oncology

What does Society of Urologic Oncology do?

The Society of Urologic Oncology (SUO) is a non-profit professional medical society that serves urologic oncology physicians through membership tiers (Active, Senior, Honorary, International, Allied Health, Affiliate, Candidate), an annual scientific meeting, ACGME-approved fellowship accreditation and match program, clinical practice guidelines, a peer-reviewed Urologic Oncology journal, and recognition through awards such as the Whitmore Lectureship, Huggins Medal, and SUO Medal. It also operates a Career Center platform and administers research grants including the NMIBC Fellows Research Grant with Ferring Pharmaceuticals.

Is Society of Urologic Oncology a public or private company?

Society of Urologic Oncology is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Society of Urologic Oncology founded?

Society of Urologic Oncology was founded in 1984. It employs 1 to 10 people.

Where is Society of Urologic Oncology based?

Society of Urologic Oncology is headquartered in Schaumburg, United States, in the North America region.

How does Society of Urologic Oncology make money?

Four revenue lines are on record. Membership Dues are the primary driver. The others are annual Meeting Registration, fellowship Programs and career Center Services.

Who are Society of Urologic Oncology's main competitors?

Direct peers on record are Society of Urologic Nurses and Associates (SUNA), American Society for Radiation Oncology (ASTRO), Society of Genitourinary Reconstructive Surgeons (GURS), American Association for Cancer Research (AACR), Society for Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) and Society of Surgical Oncology (SSO). Broad incumbents are American Urological Association (AUA) and American Society of Clinical Oncology (ASCO). Regional players are Société Internationale d'Urologie (SIU) and European Association of Urology (EAU).

Does Society of Urologic Oncology have an API?

No public API is recorded for Society of Urologic Oncology.

What industry is Society of Urologic Oncology in?

Society of Urologic Oncology's product category is Professional Medical Society Services. Its primary akta.pro industry code is HLAKAOAB, Urologic Oncology, with a secondary code of HLAKAFAM, Genitourinary Oncology. Its NAICS code is 541 and its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireAUA Announces Updates to the Early Detection of Prostate Cancer GuidelineThe American Urological Association and Society of Urologic Oncology released the 2026 amendment to the Early Detection of Prostate Cancer Guideline, which includes 35 recommendations. Updates cover digital rectal examination, 5-alpha reductase inhibitors, MRI use, and biomarker assays, with some evidence levels upgraded.PR NewswireHigh Response in Bladder Cancer: Immvira Announced Its MVR-T3011 Latest Clinical Results in BCG-Unresponsive Bladder Cancer Patients at 2025 Annual Meeting of the Society of Urologic OncologyImmVira Group announced interim clinical data for its lead product MVR-T3011 at the 2025 Annual Meeting of the Society of Urologic Oncology, showing high recurrence-free survival and complete response rates in patients with BCG-unresponsive bladder cancer. The company is currently progressing a phase II trial in the U.S. and a global multi-regional clinical trial that includes China to address significant unmet medical needs caused by BCG supply shortages.BioSpaceCG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual MeetingCG Oncology, a late-stage clinical biopharmaceutical company, announced it will present topline results from its BOND-003 Cohort P study and first results from CORE-008 Cohort A study of cretostimogene grenadenorepvec for non-muscle invasive bladder cancer at the Society of Urologic Oncology Annual Meeting in December 2025. The presentations include two late-breaking podium presentations and three poster sessions covering data from Phase 2 and Phase 3 clinical trials involving over 400 patients. The company stated these updates further reinforce cretostimogene's potential as a backbone immunotherapy across the NMIBC spectrum.GlobeNewswireSyncromune®, Inc. to Present Phase 1 Data Highlighting Resolution of Bone Metastases in Metastatic Prostate Cancer Patients at the Society of Urological Oncology 26th Annual MeetingSyncromune, Inc. announced its abstract on SYNC-T Therapy SV-102 for metastatic prostate cancer was accepted for presentation at the SUO 26th Annual Meeting in Phoenix, Arizona, Dec. 2-5, 2025. The abstract, titled "Effective resolution of bone metastases..." was selected as one of the meeting's "Top 30" submissions. The data highlights radiographic resolution of bone metastases in patients achieving complete responses.PR NewswireDiscovery Brings Bladder Cancer Patients HopeThe Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC) announced that the gene therapy nadofaragene firadenovec is under FDA review as a potential treatment for BCG-unresponsive non-muscle-invasive bladder cancer. Developed through Phase 2 and 3 trials, the therapy aims to provide an alternative to complete bladder removal for patients with this aggressive form of the disease. The SUO-CTC highlighted its collaborative role in facilitating these clinical trials alongside pharmaceutical sponsors.GlobeNewswireUroGen Pharma Announces Oral Presentation at Society of Urologic Oncology (SUO) Annual MeetingUroGen Pharma announced that Dr. Seth Lerner will present the design of its Phase 3 OLYMPUS trial of MitoGel for low-grade upper tract urothelial carcinoma at the SUO annual meeting in Washington, D.C. The trial, expected to enroll about 70 patients, will evaluate safety and tumor ablative effect, with topline data anticipated in Q2 2018.PR NewswireAUA, ASTRO and SUO Release New Clinical Guideline on Standard of Care for Men with Localized Prostate CancerThe American Urological Association (AUA), in collaboration with the American Society for Radiation Oncology (ASTRO) and the Society of Urologic Oncology (SUO), released a new evidence-based clinical guideline for managing localized prostate cancer. The guideline provides 68 statements to facilitate shared decision-making between physicians and patients, recommending active surveillance for low-risk cases and specific interventions for intermediate- or high-risk cases. This release aims to standardize care for the over 161,000 new diagnoses expected in the United States in 2017.PR NewswireAUA, ASCO, ASTRO and SUO Announce New Practice Guideline For Treatment Of Non-Metastatic Muscle-Invasive Bladder CancerThe American Urological Association, in collaboration with the American Society of Clinical Oncology, the American Society for Radiation Oncology, and the Society of Urologic Oncology, released a new joint clinical guideline for treating non-metastatic muscle-invasive bladder cancer. This framework provides recommendations on diagnosis, treatment options such as surgery and radiation, and patient surveillance to improve outcomes through a multi-disciplinary approach.